Key Insights

Highlights

Success Rate

97% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

1.8%

1 terminated out of 57 trials

Success Rate

96.7%

+10.2% vs benchmark

Late-Stage Pipeline

18%

10 trials in Phase 3/4

Results Transparency

7%

2 of 29 completed with results

Key Signals

2 with results97% success

Data Visualizations

Phase Distribution

38Total
Not Applicable (22)
P 1 (1)
P 2 (5)
P 3 (4)
P 4 (6)

Trial Status

Completed29
Unknown18
Recruiting5
Not Yet Recruiting3
Terminated1
Active Not Recruiting1

Trial Success Rate

96.7%

Benchmark: 86.5%

Based on 29 completed trials

Clinical Trials (57)

Showing 20 of 20 trials
NCT07370116Phase 2Not Yet RecruitingPrimary

Omitting Nasogastric Tube Decompression in Minimally Invasive Pancreaticoduodenectomy

NCT07412301Active Not Recruiting

The Effect of Celiac Axis Stenosis on Morbidity After Pancreatoduodenectomy - A Prospective Study

NCT06123169Phase 3Not Yet RecruitingPrimary

Postoperative Anti-infective Strategy Following Pancreaticoduodenectomy in Patients With Preoperative Biliary Stent

NCT07370987Phase 2Recruiting

Prevention of Postoperative Pancreatic Fistula Following Pancreaticoduodenectomy by Preoperative Radiotherapy : a Phase 2 Trial

NCT01950845Not ApplicableCompleted

Automated Versus Manual Fluid Management for High Risk Abdominal Surgical Patient. A Prospective, Randomized Trial

NCT05820997Phase 4TerminatedPrimary

Paravertebral Block vs no Block in Open Pancreaticoduodenectomy

NCT07230509Phase 2RecruitingPrimary

Pancreatic Parenchymal Injection of N-butyl-2-cyanoacrylate

NCT04171440Not ApplicableCompletedPrimary

Observation of Perioperative Outcomes of Robotic Pancreaticoduodenectomy

NCT07159672Completed

Cohort Study on Nutritional, Metabolic, and Volumetric Assessment After Pancreaticoduodenectomy

NCT07132541Phase 1RecruitingPrimary

Saleh's Technique for Pancreaticojejunostomy (Pancreatic Parenchymal Injection of N-butyl-2-cyanoacrylate)

NCT07038161CompletedPrimary

The Novel Modified Cattell-Warren Duct-To-Mucosa Pancreaticojejunostomy Technique Significantly Reduces POPF.

NCT07017361Not ApplicableNot Yet RecruitingPrimary

ERAS Program Implementation for MIPD

NCT05042882Not ApplicableCompletedPrimary

Enteral vs. Oral Nutrition After Pancreatoduodenectomy

NCT05523713Not ApplicableCompleted

Development and Validation of a Predictive Score for Surgical Site Infections

NCT05581017Completed

Association of Cephalosporin Resistance and Surgical Site Infections in Patients Undergoing Pancreaticoduodenectomy

NCT06863389CompletedPrimary

Comparison of Chen's U-suture Technique with Duct-to-Mucosa Anastomosis and Invagination Pancreaticojejunostomy After Pancreaticoduodenectomy

NCT06322680Not ApplicableRecruitingPrimary

Impact of External Drainage of the Main Pancreatic Duct and Common Bile Duct on Pancreatic Fistula Following Pancreaticoduodenectomy

NCT06763250Unknown

In This Study, a Retrospective Analysis Was Conducted to Explore the Risk Factors for Patients Undergoing Pancreaticoduodenal Surgery (PD) to Achieve TO, and a Nomogram Prediction Model Was Further Established to Promote the Standardization and Standardization of PD Surgical Quality Evaluation.

NCT05680623Completed

Clinical and Economic Validation of the ISGPS Definition of PPAP

NCT06119880Phase 4Unknown

The Effect of PERT on Patients Undergoing Pancreaticoduodenectomy

Scroll to load more

Research Network

Activity Timeline